Ποια είναι η τιμή για Hancock Jaffe Laboratories (HJLI)

Η τιμή για Hancock Jaffe Laboratories (HJLI) είναι $10.38

Ποια είναι η κεφαλαιοποίηση αγοράς για Hancock Jaffe Laboratories (HJLI)

Η κεφαλαιοποίηση αγοράς για Hancock Jaffe Laboratories (HJLI) είναι $4.55M

Hancock Jaffe Laboratories (HJLI) Τιμή και Κεφαλαιοποίηση Αγοράς

Hancock Jaffe Laboratories, Inc. is a medical device company in its developmental stage, specializing in creating advanced tissue-based and biologic solutions. These innovations are engineered to either sustain or significantly enhance the lives of patients afflicted with cardiovascular, peripheral arterial, and venous diseases, as well as end-stage renal disease (ESRD). The firm, headquartered in Irvine, California, maintains a dedicated team of nine full-time employees. Among its key initiatives, the company is actively developing implantable bioprosthetic devices for cardiovascular applications. This includes the Bioprosthetic Heart Valve (BHV), a swine-derived heart valve designed to mimic the function of a native heart valve and provide superior performance compared to current prosthetic options. Furthermore, the company is developing a Venous Valve, another bioprosthetic device sourced from pig tissue. This valve is specifically designed for individuals suffering from chronic venous insufficiency (CVI) in the lower limbs, a condition frequently resulting from damage to leg vein valves after the formation of deep venous blood clots.

Η τιμή για HJLI	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$12,426,348 $4.55M	NVDA	$5.452T	+119,714,238.29%
$10,234,026 $4.55M	AAPL	$4.490T	+98,593,596.65%
$9,487,303 $4.55M	GOOG	$4.162T	+91,399,733.29%
$8,379,424 $4.55M	MSFT	$3.676T	+80,726,528.74%
$6,457,305 $4.55M	AMZN	$2.833T	+62,209,007.02%

Η τιμή για HJLI

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$12,426,348 $4.55M